NKTX Nkarta, Inc. - Common Stock
NKTX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
NKTX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
NKTX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 4 33,3%
- Kup 7 58,3%
- Trzymaj 1 8,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
6 analityków · 2026-08-15Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.54 | $-0.38 | -0.16% |
| 31 marca 2026 | $-0.37 | $-0.38 | 0.01% |
| 31 grudnia 2025 | $-0.37 | $-0.32 | -0.05% |
| 30 września 2025 | $-0.29 | $-0.32 | 0.03% |
| 30 czerwca 2025 | $-0.31 | $-0.36 | 0.05% |
| 31 marca 2025 | $-0.43 | $-0.45 | 0.02% |
| 31 grudnia 2024 | $-0.35 | $-0.42 | 0.07% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | — |
| OKUR | — | -0.7 | — | -1733.7% | -88.6% | — |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| CNTN | $112M | -2.7 | — | — | -18.0% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | $0 | · | $115.0K | |
| R&D Expense | $90M | $97M | $97M | $91M | $63M | $36M | $17M | |
| SG&A Expense | $32M | $31M | $35M | $28M | $23M | $15M | $5M | |
| Operating Expenses | $122M | $128M | $132M | $119M | $86M | $52M | $22M | |
| Operating Income | $-122M | $-128M | $-132M | $-119M | $-86M | $-52M | $-22M | |
| Other Non-op | $2M | $87.0K | $42.0K | $-470.0K | $-16.0K | $-3.0K | $18.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-104M | $-109M | $-118M | $-114M | $-86M | $-91M | $-21M | |
| EPS (Basic) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · | |
| EPS (Diluted) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · | |
| Shares (Basic) | 73,991,197 | 67,865,323 | 49,014,300 | 43,631,722 | 32,856,883 | · | · | |
| Shares (Diluted) | 73,991,197 | 67,865,323 | 49,014,300 | 43,631,722 | 32,856,883 | · | · | |
| EBITDA | $-113M | $-119M | $-126M | $-116M | $-85M | $-51M | · |
Bilans 22
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40M | $28M | $31M | $37M | $61M | $97M | $21M | |
| Short-term Investments | $237M | $239M | $217M | $315M | $177M | $218M | $16M | |
| Prepaid Expense | $6M | $6M | $5M | $9M | $8M | $4M | $474.0K | |
| Other Current Assets | $2M | $3M | $2M | $3M | $3M | $1M | $67.0K | |
| Current Assets | $283M | $273M | $253M | $361M | $246M | $319M | $37M | |
| PP&E (Net) | $67M | $75M | $79M | $62M | $13M | $9M | $3M | |
| PP&E (Gross) | $96M | $96M | $91M | $68M | $16M | $11M | $4M | |
| Accum. Depreciation | $29M | $21M | $12M | $6M | $3M | $1M | $645.0K | |
| Other Non-current Assets | $2M | $4M | $4M | $2M | $1M | $547.0K | $455.0K | |
| Total Assets | $404M | $501M | $379M | $473M | $274M | $338M | $48M | |
| Accounts Payable | $2M | $638.0K | $4M | $2M | $1M | $1M | $2M | |
| Accrued Liabilities | $13M | $12M | $14M | $16M | $9M | $6M | $3M | |
| Current Liabilities | $22M | $19M | $23M | $22M | $13M | $9M | $8M | |
| Capital Leases | $70M | $74M | $82M | $79M | $10M | $8M | $6M | |
| Other Non-current Liabilities | $87.0K | $87.0K | · | · | $18.0K | $82.0K | $134.0K | |
| Total Liabilities | $92M | $93M | $106M | $101M | $23M | $16M | $14M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-648M | $-544M | $-435M | $-318M | $-204M | $-118M | $-27M | |
| AOCI | $407.0K | $674.0K | $8.0K | $-679.0K | $-150.0K | $3.0K | $-2.0K | |
| Stockholders' Equity | $312M | $408M | $273M | $372M | $251M | $321M | $-25M | |
| Liabilities + Equity | $404M | $501M | $379M | $473M | $274M | $338M | $48M | |
| Shares Outstanding | 71,078,531 | 70,645,139 | 49,181,295 | 48,877,806 | 32,971,107 | 32,627,963 | 1,600,601 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $9M | $6M | $3M | $2M | $800.0K | $400.0K | |
| Stock-based Comp | $9M | $17M | $17M | $17M | $14M | $7M | $947.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-2M | $-17M | $8M | $37M | $2M | $40M | · | |
| Operating Cash Flow | $-89M | $-100M | $-86M | $-57M | $-68M | $-44M | $-18M | |
| CapEx | $1M | $4M | $28M | $47M | $5M | $8M | $2M | |
| Investing Cash Flow | $100M | $-130M | $79M | $-185M | $33M | $-210M | $-18M | |
| Financing Cash Flow | $141.0K | $226M | $691.0K | $219M | $1M | $330M | $50M | |
| Net Change in Cash | $12M | $-3M | $-6M | $-23M | $-34M | $76M | $13M | |
| Free Cash Flow | $-90M | $-104M | $-114M | $-104M | $-73M | $-51M | · |
Rentowność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -23.0% | -24.7% | -27.6% | -30.5% | -28.1% | -47.3% | · | |
| ROE | -31.1% | -25.9% | -41.2% | -29.5% | -33.0% | -27.9% | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.7 | 14.4 | 10.8 | 16.4 | 19.0 | 36.1 | · | |
| Quick Ratio | 12.4 | 14.1 | 10.6 | 16.0 | 18.4 | 35.7 | · |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | 0.0 | · | · |
Wycena (TTM) 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | · | $0 | · | · | |
| Net Income TTM | $-104M | $-109M | $-118M | $-114M | $-86M | $-91M | · | |
| Market Cap | $131M | $176M | $325M | $293M | $506M | $2.01B | · | |
| P/E | -1.3 | -1.6 | -2.8 | -2.3 | -5.9 | · | · | |
| P/B | 0.4 | 0.4 | 1.2 | 0.8 | 2.0 | 6.2 | · | |
| P / Tangible Book | 0.4 | 0.4 | 1.2 | 0.8 | 2.0 | 6.2 | · | |
| P / Cash Flow | -1.5 | -1.8 | -3.8 | -5.1 | -7.5 | -46.1 | · | |
| P / FCF | -1.5 | -1.7 | -2.8 | -2.8 | -6.9 | -39.3 | · | |
| Earnings Yield | -76.2% | -64.3% | -36.4% | -43.6% | -17.1% | · | · |
Rachunek zysków i strat 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $25M | $25M | $20M | $21M | $24M | $23M | $25M | $23M | $25M | $23M | $22M | $25M | $26M | $27M | $23M | |
| SG&A Expense | $14M | $6M | $6M | $7M | $6M | $12M | $8M | $9M | $8M | $8M | $8M | $7M | $12M | $8M | $8M | $7M | |
| Operating Expenses | $43M | $31M | $31M | $27M | $27M | $37M | $31M | $34M | $31M | $33M | $31M | $29M | $37M | $34M | $35M | $30M | |
| Operating Income | $-43M | $-31M | $-31M | $-27M | $-27M | $-37M | $-31M | $-34M | $-31M | $-33M | $-31M | $-29M | $-37M | $-34M | $-35M | $-30M | |
| Other Non-op | $222.0K | $206.0K | $256.0K | $2M | $239.0K | $205.0K | $94.0K | $-3.0K | $-2.0K | $-2.0K | $-25.0K | $33.0K | $1.0K | $33.0K | $-489.0K | $17.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-40M | $-28M | $-27M | $-22M | $-23M | $-32M | $-26M | $-28M | $-25M | $-30M | $-28M | $-26M | $-33M | $-31M | $-33M | $-28M | |
| EPS (Basic) | $-0.54 | $-0.37 | $-0.38 | $-0.29 | $-0.31 | $-0.43 | $-0.29 | $-0.39 | $-0.34 | $-0.58 | $-0.57 | $-0.52 | $-0.68 | $-0.63 | $-0.63 | $-0.58 | |
| EPS (Diluted) | $-0.54 | $-0.37 | $-0.38 | $-0.29 | $-0.31 | $-0.43 | $-0.29 | $-0.39 | $-0.34 | $-0.58 | $-0.57 | $-0.52 | $-0.68 | $-0.63 | $-0.63 | $-0.58 | |
| Shares (Basic) | 74,494,855 | 74,257,973 | -147,927,448 | 74,024,543 | 73,977,625 | 73,916,477 | -129,874,985 | 73,563,316 | 73,494,523 | 50,682,469 | -97,940,216 | 49,062,799 | 48,970,391 | 48,921,326 | -81,832,580 | 48,630,328 | |
| Shares (Diluted) | 74,494,855 | 74,257,973 | -147,927,448 | 74,024,543 | 73,977,625 | 73,916,477 | -129,874,985 | 73,563,316 | 73,494,523 | 50,682,469 | -97,940,216 | 49,062,799 | 48,970,391 | 48,921,326 | -81,832,580 | 48,630,328 | |
| EBITDA | $-40M | $-29M | · | $-25M | $-25M | $-34M | · | $-31M | $-28M | $-30M | · | $-27M | $-36M | $-34M | · | $-30M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $27M | $40M | $60M | $53M | $53M | $28M | $57M | $120M | $250M | $31M | $38M | $29M | $54M | $37M | $40M | |
| Short-term Investments | $158M | $203M | $237M | $222M | $236M | $213M | $239M | $226M | $204M | $187M | $217M | $237M | $252M | $270M | $315M | $353M | |
| Prepaid Expense | $5M | $5M | $6M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | $6M | $6M | $9M | $9M | $9M | |
| Other Current Assets | · | · | $2M | · | · | · | $3M | · | · | · | $2M | $2M | $3M | $3M | $3M | $3M | |
| Current Assets | $188M | $236M | $283M | $289M | $297M | $272M | $273M | $290M | $332M | $443M | $253M | $281M | $287M | $332M | $361M | $401M | |
| PP&E (Net) | $57M | $64M | $67M | $68M | $70M | $73M | $75M | $76M | $78M | $79M | $79M | $78M | $76M | $70M | $62M | $30M | |
| PP&E (Gross) | $93M | $96M | $96M | $96M | $96M | $96M | $96M | $95M | $94M | $92M | $91M | $87M | $84M | $76M | $68M | $35M | |
| Accum. Depreciation | $36M | $31M | $29M | $28M | $25M | $23M | $21M | $19M | $16M | $14M | $12M | $9M | $7M | $7M | $6M | $5M | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $2M | |
| Total Assets | $338M | $372M | $404M | $427M | $448M | $471M | $501M | $532M | $554M | $577M | $379M | $406M | $429M | $458M | $473M | $504M | |
| Accounts Payable | $4M | $2M | $2M | $1M | $2M | $1M | $638.0K | $2M | $4M | $3M | $4M | $4M | $3M | $5M | $2M | $9M | |
| Accrued Liabilities | $12M | $10M | $13M | $11M | $11M | $11M | $12M | $14M | $12M | $13M | $14M | $15M | $18M | $15M | $16M | $12M | |
| Current Liabilities | $24M | $18M | $22M | $19M | $19M | $19M | $19M | $22M | $21M | $22M | $23M | $26M | $27M | $26M | $22M | $26M | |
| Capital Leases | $66M | $68M | $70M | $70M | $72M | $73M | $74M | $79M | $80M | $81M | $82M | $83M | $84M | $86M | $79M | $78M | |
| Other Non-current Liabilities | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | · | · | · | · | · | · | · | · | $5.0K | |
| Total Liabilities | $90M | $86M | $92M | $89M | $91M | $92M | $93M | $101M | $101M | $103M | $106M | $109M | $111M | $112M | $101M | $105M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-717M | $-676M | $-648M | $-621M | $-599M | $-576M | $-544M | $-518M | $-490M | $-465M | $-435M | $-408M | $-382M | $-349M | $-318M | $-285M | |
| AOCI | $-425.0K | $-130.0K | $407.0K | $536.0K | $362.0K | $652.0K | $674.0K | $2M | $-263.0K | $-127.0K | $8.0K | $-409.0K | $-601.0K | $-174.0K | $-679.0K | $-1M | |
| Stockholders' Equity | $248M | $286M | $312M | $338M | $358M | $379M | $408M | $431M | $453M | $474M | $273M | $297M | $318M | $347M | $372M | $399M | |
| Liabilities + Equity | $338M | $372M | $404M | $427M | $448M | $471M | $501M | $532M | $554M | $577M | $379M | $406M | $429M | $458M | $473M | $504M | |
| Shares Outstanding | · | · | 71,078,531 | · | · | · | 70,645,139 | · | · | · | 49,181,295 | · | · | · | 48,877,806 | · |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $800.0K | $800.0K | $700.0K | $700.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | |
| Restructuring | · | · | $-59.0K | $-26.0K | $-86.0K | $5M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-5M | · | · | · | $-3M | · | · | · | $-6M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-24M | $-28M | $-22M | $-19M | $-19M | $-30M | $-25M | $-25M | $-22M | $-29M | $-23M | $-20M | $-22M | $-21M | $-7M | $-15M | |
| CapEx | $183.0K | $413.0K | $560.0K | $-8.0K | $138.0K | $518.0K | $1M | $777.0K | $2M | $175.0K | $7M | $6M | $10M | $5M | $35M | $8M | |
| Investing Cash Flow | $21M | $16M | $1M | $25M | $19M | $54M | $-5M | $-39M | $-108M | $21M | $16M | $29M | $-3M | $37M | $5M | $-79M | |
| Financing Cash Flow | $676.0K | $6.0K | $64.0K | $0 | $77.0K | $0 | $184.0K | $2.0K | $-368.0K | $226M | $295.0K | $0 | $395.0K | $1.0K | $424.0K | $3M | |
| Net Change in Cash | $-2M | $-12M | $-20M | $7M | $816.0K | $25M | $-29M | $-63M | $-130M | $219M | $-7M | $9M | $-25M | $16M | $-2M | $-91M | |
| Free Cash Flow | · | $-29M | · | · | · | $-30M | · | · | · | $-29M | · | · | · | $-26M | · | · |
Rentowność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.3% | -6.6% | · | -4.5% | -4.6% | -6.1% | · | -6.0% | -5.1% | -5.7% | · | -5.6% | -7.1% | -8.1% | · | -7.1% | |
| ROE | -13.3% | -8.4% | · | -5.7% | -5.7% | -7.5% | · | -7.8% | -6.5% | -7.2% | · | -7.4% | -9.0% | -10.7% | · | -8.5% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 13.0 | · | 15.2 | 15.7 | 14.5 | · | 12.9 | 15.9 | 20.0 | · | 11.0 | 10.8 | 12.8 | · | 15.2 | |
| Quick Ratio | 7.8 | 12.7 | · | 14.9 | 15.3 | 14.2 | · | 12.6 | 15.6 | 19.7 | · | 10.7 | 10.5 | 12.4 | · | 14.8 |
Wycena (TTM) 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-113M | $-105M | · | $-105M | $-108M | $-115M | · | $-108M | $-113M | $-119M | · | $-118M | $-119M | $-112M | · | $-104M | |
| P/E | -1.9 | -1.5 | · | -1.5 | -1.1 | -1.1 | · | -2.5 | -2.8 | -4.5 | · | -0.6 | -0.9 | -1.4 | · | -4.9 | |
| Earnings Yield | -53.4% | -66.3% | · | -68.6% | -88.5% | -94.6% | · | -40.5% | -35.9% | -22.3% | · | -173.4% | -114.2% | -73.5% | · | -20.2% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $0 | $0 | — | — | $0 |
| Zysk netto | $-104M | $-109M | $-118M | $-114M | $-86M |
| Rozwodniony EPS | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 12.7 | 14.4 | 10.8 | 16.4 | 19.0 |
| Wskaźnik Szybkości | 12.4 | 14.1 | 10.6 | 16.0 | 18.4 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-90M | $-104M | $-114M | $-104M | $-73M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 148 emitentów · $137.5M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 32 (+14 vs poprzedni kw.) | 13 (+4 vs poprzedni kw.) | 46 (+2 vs poprzedni kw.) | 34 (+6 vs poprzedni kw.) | +943K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $30 578 515 | 10 805 129 | 22,24% | Akcje |
| NEA Management Company, LLC | $10 099 650 | 3 568 781 | 7,35% | Akcje |
| SAMSARA BIOCAPITAL, LLC | $9 926 695 | 3 507 666 | 7,22% | Akcje |
| SR One Capital Management, LP | $9 433 332 | 3 333 333 | 6,86% | Akcje |
| GSK plc | $8 916 572 | 3 150 732 | 6,48% | Akcje |
| Monaco Asset Management SAM | $6 716 722 | 2 373 400 | 4,88% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 300 754 | 2 226 415 | 4,58% | Akcje |
| CITADEL ADVISORS LLC | $6 154 528 | 2 174 745 | 4,48% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $5 301 419 | 1 873 293 | 3,86% | Akcje |
| STATE STREET CORP | $3 639 688 | 1 286 109 | 2,65% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $3 332 755 | 1 177 652 | 2,42% | Akcje |
| WASATCH ADVISORS LP | $3 329 257 | 1 577 847 | 2,42% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $3 126 052 | 1 104 344 | 2,27% | Akcje |
| AWM Investment Company, Inc. | $2 563 980 | 906 000 | 1,86% | Akcje |
| BlackRock, Inc. | $2 220 384 | 784 588 | 1,61% | Akcje |
| Blackstone Inc. | $2 114 135 | 747 044 | 1,54% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $1 650 595 | 583 249 | 1,20% | Akcje |
| Peapod Lane Capital LLC | $1 556 282 | 549 923 | 1,13% | Akcje |
| JPMORGAN CHASE & CO | $1 548 938 | 543 487 | 1,13% | Akcje |
| Alyeska Investment Group, L.P. | $1 372 097 | 484 840 | 1,00% | Akcje |
| TWO SIGMA ADVISERS, LP | $1 197 320 | 647 200 | 0,87% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $1 186 308 | 419 190 | 0,86% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $985 366 | 348 186 | 0,72% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $915 955 | 323 659 | 0,67% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $854 422 | 301 916 | 0,62% | Akcje |
| XTX Topco Ltd | $820 658 | 289 985 | 0,60% | Akcje |
| GOLDMAN SACHS GROUP INC | $754 846 | 266 730 | 0,55% | Akcje |
| VANGUARD GROUP INC | $604 970 | 327 011 | 0,44% | Akcje |
| IEQ CAPITAL, LLC | $501 017 | 177 038 | 0,36% | Akcje |
| D. E. Shaw & Co., Inc. | $415 574 | 146 846 | 0,30% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $370 659 | 130 975 | 0,27% | Akcje |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $367 900 | 130 000 | 0,27% | Akcje |
| FMR LLC | $365 710 | 129 226 | 0,27% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $357 539 | 126 339 | 0,26% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $347 524 | 122 800 | 0,25% | Akcje |
| Qube Research & Technologies Ltd | $341 889 | 120 809 | 0,25% | Akcje |
| BARCLAYS PLC | $341 733 | 120 754 | 0,25% | Akcje |
| MACKENZIE FINANCIAL CORP | $325 985 | 115 189 | 0,24% | Akcje |
| JANE STREET GROUP, LLC | $315 899 | 111 625 | 0,23% | Akcje |
| Point72 Asset Management, L.P. | $302 261 | 106 806 | 0,22% | Akcje |
| Man Group plc | $283 133 | 100 047 | 0,21% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $268 428 | 94 851 | 0,20% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $233 922 | 82 658 | 0,17% | Akcje |
| CITADEL ADVISORS LLC | $229 230 | 81 000 | 0,17% | Opcja kupna |
| Mariner, LLC | $222 169 | 78 504 | 0,16% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $213 005 | 100 950 | 0,15% | Akcje |
| Marquette Asset Management, LLC | $212 451 | 75 071 | 0,15% | Akcje |
| Empowered Funds, LLC | $197 087 | 69 642 | 0,14% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188 886 | 66 744 | 0,14% | Akcje |
| HSBC HOLDINGS PLC | $183 463 | 65 994 | 0,13% | Akcje |
| RHUMBLINE ADVISERS | $171 129 | 60 473 | 0,12% | Akcje |
| Rangeley Capital, LLC | $169 800 | 60 000 | 0,12% | Akcje |
| BANK OF AMERICA CORP /DE/ | $161 250 | 56 979 | 0,12% | Akcje |
| PRELUDE CAPITAL MANAGEMENT, LLC | $151 688 | 53 600 | 0,11% | Akcje |
| Verdad Advisers, LP | $145 753 | 51 503 | 0,11% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $142 985 | 48 143 | 0,10% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $115 656 | 40 868 | 0,08% | Akcje |
| Samalin Investment Counsel, LLC | $115 323 | 40 750 | 0,08% | Akcje |
| Bank of New York Mellon Corp | $109 954 | 38 853 | 0,08% | Akcje |
| WELLS FARGO & COMPANY/MN | $105 950 | 37 438 | 0,08% | Akcje |
| Cerity Partners LLC | $105 858 | 37 406 | 0,08% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $95 445 | 33 726 | 0,07% | Akcje |
| CWM, LLC | $89 954 | 42 632 | 0,07% | Akcje |
| Forefront Analytics, LLC | $81 943 | 28 955 | 0,06% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $81 221 | 28 700 | 0,06% | Akcje |
| MARSHALL WACE, LLP | $80 172 | 28 329 | 0,06% | Akcje |
| BANK OF MONTREAL /CAN/ | $78 796 | 27 843 | 0,06% | Akcje |
| Cubist Systematic Strategies, LLC | $71 083 | 34 340 | 0,05% | Akcje |
| Graham Capital Management, L.P. | $67 858 | 23 978 | 0,05% | Akcje |
| Abel Hall, LLC | $65 783 | 23 245 | 0,05% | Akcje |
| SIMPLEX TRADING, LLC | $65 135 | 23 016 | 0,05% | Akcje |
| Nuveen, LLC | $64 490 | 22 788 | 0,05% | Akcje |
| Creative Planning | $62 232 | 21 990 | 0,05% | Akcje |
| Vanguard Personalized Indexing Management, LLC | $59 605 | 21 062 | 0,04% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $58 253 | 20 584 | 0,04% | Akcje |
| Nuveen Asset Management, LLC | $56 742 | 22 788 | 0,04% | Akcje |
| JANE STREET GROUP, LLC | $56 600 | 20 000 | 0,04% | Opcja kupna |
| CAPTRUST FINANCIAL ADVISORS | $52 397 | 18 515 | 0,04% | Akcje |
| Vanguard Global Advisers, LLC | $51 209 | 18 095 | 0,04% | Akcje |
| CITIGROUP INC | $51 104 | 18 058 | 0,04% | Akcje |
| Invesco Ltd. | $50 682 | 17 909 | 0,04% | Akcje |
| DIVERSIFIED TRUST CO | $49 137 | 17 363 | 0,04% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48 676 | 17 200 | 0,04% | Opcja sprzedaży |
| WINTON GROUP Ltd | $44 714 | 15 800 | 0,03% | Akcje |
| BRIGHTON JONES LLC | $41 746 | 14 751 | 0,03% | Akcje |
| Merit Financial Group, LLC | $39 343 | 13 902 | 0,03% | Akcje |
| Focus Partners Wealth | $36 620 | 12 940 | 0,03% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $35 313 | 12 478 | 0,03% | Akcje |
| Arax Advisory Partners | $34 130 | 12 060 | 0,02% | Akcje |
| Spark Investment Management LLC | $33 111 | 11 700 | 0,02% | Akcje |
| Quadrature Capital Ltd | $32 568 | 11 508 | 0,02% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $30 887 | 10 914 | 0,02% | Akcje |
| Pallas Capital Advisors LLC | $30 708 | 10 851 | 0,02% | Akcje |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $30 352 | 10 725 | 0,02% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $30 106 | 10 638 | 0,02% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $28 297 | 9 999 | 0,02% | Akcje |
| UBS Group AG | $26 557 | 9 384 | 0,02% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $23 928 | 8 455 | 0,02% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $23 115 | 8 168 | 0,02% | Akcje |
| Tower Research Capital LLC (TRC) | $22 665 | 8 009 | 0,02% | Akcje |
Insiderzy spółki 27 insiderów · 10 dyrektorzy generalni · 11 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul J Hastings | Chief Executive Officer | 18 czerwca 2026 S | 390 247 | 0 | 2 | $-58 728 |
| Matthew Plunkett | Chief Financial Officer | 9 lipca 2020 A | — | 0 | 0 | $0 |
| Nadir Mahmood | President | 15 stycznia 2026 S | 167 727 | 0 | 1 | $-11 693 |
| Shawn Marshall Rose | Chief Medical Officer, Head of Research & Development | 6 stycznia 2026 A | 70 000 | 0 | 0 | $0 |
| Alyssa Levin | Chief Financial and Business Officer | 15 stycznia 2025 S | 102 662 | 0 | 0 | $0 |
| David Shook | Chief Medical Officer, Head of Research & Development | 15 stycznia 2025 S | 190 955 | 0 | 0 | $0 |
| Ralph Brandenberger | Chief Technical Officer | 15 stycznia 2025 S | 124 796 | 0 | 0 | $0 |
| Alicia J. Hager | Chief Legal Officer | 15 stycznia 2025 S | 146 735 | 0 | 0 | $0 |
| James Trager | Chief Scientific Officer | 18 czerwca 2024 S | 150 959 | 0 | 0 | $0 |
| Kanya Rajangam | Chief Medical Officer | 14 stycznia 2022 A | 12 800 | 0 | 0 | $0 |
| George Vratsanos | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Zachary Scheiner | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Angela Thedinga | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Ali Behbahani | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Michael Dybbs | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Simeon George | Dyrektor | 10 czerwca 2026 A | 451 659 | 0 | 0 | $0 |
| Leone D Patterson | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Fouad Oscar Azzam | Dyrektor | 7 czerwca 2023 A | — | 0 | 0 | $0 |
| Tiba Aynechi | Dyrektor | 8 czerwca 2022 A | — | 0 | 0 | $0 |
| Laura Shawver | Dyrektor | 8 czerwca 2022 A | — | 0 | 0 | $0 |
| Mohamad Makhzoumi | Posiadacz 10% | 14 lipca 2020 C | 2 902 115 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | Posiadacz 10% | 14 lipca 2020 C | 2 902 115 | 0 | 0 | $0 |
| Peter W. Sonsini | Posiadacz 10% | 14 lipca 2020 C | 2 902 115 | 0 | 0 | $0 |
| Novo Holdings A/S | Posiadacz 10% | 14 lipca 2020 C | 2 793 865 | 0 | 0 | $0 |
| Forest Baskett | Posiadacz 10% | 14 lipca 2020 C | 2 902 115 | 0 | 0 | $0 |
| Scott D. Sandell | Posiadacz 10% | 14 lipca 2020 C | 2 902 115 | 0 | 0 | $0 |
| Joshua Makower | Posiadacz 10% | 14 lipca 2020 C | 2 902 115 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 5 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×4 zgłoszenia | 19 maja 2026 | 4,90% | Aneks | Inwestycja pasywna | SEC |
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Srinivas Akkaraju ×4 zgłoszenia | 24 listopada 2025 | 4,90% | Aneks | — | SEC |
| LSP 6 Management B.V., LSP 6 Holding C.V., LSP 6 NK Holding B.V ×3 zgłoszenia | 12 lutego 2025 | 4,00% | Aneks | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×3 zgłoszenia | 29 marca 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Novo Holdings A/S ×4 zgłoszenia | 3 czerwca 2022 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 23 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,07% | 80 561 SH | 8 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,02% | 150 315 SH | 8 sierpnia 2026 | Dziennie |
| SFGV · EA Series Trust | 0,02% | 69 747 NS | 29 maja 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 90 267 NS | 31 maja 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 38 962 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 103 003 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,01% | 450 360 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,00% | 2 199 NS | 31 maja 2026 | N-PORT |
| RSSL · Global X Funds | 0,00% | 19 275 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1 120 883 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 137 619 NS | 30 kwietnia 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 719 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 737 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 985 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 44 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6 031 NS | 30 kwietnia 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 8 873 SH | 8 sierpnia 2026 | Dziennie |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 3 657 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 599 527 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 567 021 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 259 168 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 786 SH | 8 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 6 442 NS | 30 kwietnia 2026 | N-PORT |